📣 VC round data is live. Check it out!
- Public Comps
- BrightSpring Health
BrightSpring Health Valuation Multiples
Discover BrightSpring Health's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Ensign Group, Alibaba Health, JD Health, Droga Raia and more.
BrightSpring Health Overview
About BrightSpring Health
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Founded
2017
HQ

Employees
37.0K
Website
Sectors
Financials (LTM)
EV
$13B
Valuation Multiples
Start free trialBrightSpring Health Financials
BrightSpring Health reported last 12-month revenue of $14B and EBITDA of $699M.
In the same LTM period, BrightSpring Health generated $2B in gross profit, $699M in EBITDA, and $258M in net income.
Revenue (LTM)
BrightSpring Health P&L
In the most recent fiscal year, BrightSpring Health reported revenue of $13B and EBITDA of $618M.
BrightSpring Health is profitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 5%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
BrightSpring Health Stock Performance
BrightSpring Health has current market cap of $12B, and enterprise value of $13B.
Market Cap Evolution
BrightSpring Health's stock price is $59.98.
BrightSpring Health share price decreased by 2.7% in the last 30 days, and increased by 156.1% in the last year.
BrightSpring Health has an EPS (earnings per share) of $0.98.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13B | $12B | -2.7% | -2.7% | 41.6% | 156.1% | $0.98 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBrightSpring Health Valuation Multiples
BrightSpring Health trades at 1.0x EV/Revenue multiple, and 19.2x EV/EBITDA.
EV / Revenue (LTM)
BrightSpring Health Financial Valuation Multiples
As of June 2, 2026, BrightSpring Health has market cap of $12B and EV of $13B.
BrightSpring Health has a P/E ratio of 45.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BrightSpring Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


BrightSpring Health Margins & Growth Rates
BrightSpring Health grew revenue by 17% and EBITDA by 31% in the last fiscal year.
In the most recent fiscal year, BrightSpring Health reported gross margin of 12%, EBITDA margin of 5%, and net margin of 1%.
BrightSpring Health Margins
BrightSpring Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
BrightSpring Health Operational KPIs
BrightSpring Health's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.
BrightSpring Health's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BrightSpring Health's Rule of X is 47% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
BrightSpring Health Competitors
BrightSpring Health competitors include Ensign Group, Alibaba Health, JD Health, Droga Raia, MatsukiyoCocokara, Chemed, Tsuruha Holdings, Hinge Health, CR Pharmaceutical and Dr. Sulaiman Al Habib.
Most BrightSpring Health public comparables operate across Pharmacies and Long-Term Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.2x | 2.1x | 18.8x | 17.6x | |||
| 1.4x | 1.2x | 25.9x | 21.0x | |||
| 0.8x | 0.8x | 9.6x | 12.0x | |||
| 0.9x | 0.9x | 11.5x | 11.4x | |||
| 0.8x | 0.7x | 7.6x | 7.4x | |||
| 2.3x | 2.2x | 12.7x | 12.3x | |||
| 0.6x | 0.5x | 8.9x | 8.3x | |||
| 7.8x | 6.8x | 38.0x | 28.6x | |||
This data is available for Pro users. Sign up to see all BrightSpring Health competitors and their valuation data. Start Free Trial | ||||||
BrightSpring Health VC Funding History
Before going public, BrightSpring Health raised $335M in total equity funding, across 2 rounds.
BrightSpring Health Funding Rounds
Acquisitions by BrightSpring Health
BrightSpring Health has acquired 3 companies to date.
Last acquisition by BrightSpring Health was on June 24th 2024. BrightSpring Health acquired Haven for $60M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by BrightSpring Health
| Description | Haven Hospice is a provider of palliative care services supporting patients, families, and healthcare providers facing advanced illnesses. | Abode Healthcare is a provider of home health and hospice services across 10 U.S. states including Texas and Oklahoma. Acquired by Amedisys in 2021, it operates 20 agencies serving over 5,000 patients annually with skilled nursing, therapy, and palliative care. The firm tailors plans to individual needs in growing markets like the Southeast, emphasizing personalized attention and family support. | Advanced Home Care is the largest Medicare- and Medicaid-certified home health organization in the Southeast United States, headquartered in Georgia. It delivers skilled nursing, physical therapy, occupational therapy, speech therapy, home health aides, and medical social services to patients across multiple states. The provider supports recovery from hospital stays, chronic conditions, and palliative care needs. |
| HQ Country | |||
| HQ City | Gainesville, FL | Durango, CO | Greensboro, NC |
| Deal Date | 24 Jun 2024 | 16 Apr 2021 | 6 Mar 2020 |
| Valuation | $60M | $775M | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all BrightSpring Health acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BrightSpring Health
| When was BrightSpring Health founded? | BrightSpring Health was founded in 2017. |
| Where is BrightSpring Health headquartered? | BrightSpring Health is headquartered in United States. |
| How many employees does BrightSpring Health have? | As of today, BrightSpring Health has over 37K employees. |
| Who is the CEO of BrightSpring Health? | BrightSpring Health's CEO is Jon B. Rousseau. |
| Is BrightSpring Health publicly listed? | Yes, BrightSpring Health is a public company listed on Nasdaq. |
| What is the stock symbol of BrightSpring Health? | BrightSpring Health trades under BTSG ticker. |
| When did BrightSpring Health go public? | BrightSpring Health went public in 2024. |
| Who are competitors of BrightSpring Health? | BrightSpring Health main competitors include Ensign Group, Alibaba Health, JD Health, Droga Raia, MatsukiyoCocokara, Chemed, Tsuruha Holdings, Hinge Health, CR Pharmaceutical, Dr. Sulaiman Al Habib. |
| What is the current market cap of BrightSpring Health? | BrightSpring Health's current market cap is $12B. |
| What is the current revenue of BrightSpring Health? | BrightSpring Health's last 12 months revenue is $14B. |
| What is the current revenue growth of BrightSpring Health? | BrightSpring Health revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of BrightSpring Health? | Current revenue multiple of BrightSpring Health is 1.0x. |
| What is the current EBITDA of BrightSpring Health? | BrightSpring Health's last 12 months EBITDA is $699M. |
| What is BrightSpring Health's EBITDA margin? | BrightSpring Health's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of BrightSpring Health? | Current EBITDA multiple of BrightSpring Health is 19.2x. |
| What is the current FCF of BrightSpring Health? | BrightSpring Health's last 12 months FCF is $415M. |
| What is BrightSpring Health's FCF margin? | BrightSpring Health's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of BrightSpring Health? | Current FCF multiple of BrightSpring Health is 32.4x. |
| How many companies BrightSpring Health has acquired to date? | As of June 2026, BrightSpring Health has acquired 3 companies. |
| What was the largest acquisition by BrightSpring Health? | $775M acquisition of Abode Healthcare on 16th April 2021 was the largest M&A BrightSpring Health has done to date. |
| What companies BrightSpring Health acquired? | BrightSpring Health acquired Abode Healthcare, Haven, and Advanced Home Care. |
| In how many companies BrightSpring Health has invested to date? | BrightSpring Health hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to BrightSpring Health
Lists including BrightSpring Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
